Fall 2014 - Innovation

Vaccination Coverage Among Kids 13-17 Rises

An analysis by the Centers for Disease Control and Prevention (CDC) has found that vaccination coverage among adolescents ages 13 to 17 years rose between 2012 and 2013. CDC analyzed data from the 2013 National Immunization Survey-Teen and found that coverage increased for each of the vaccines routinely recommended for adolescents, which includes tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) from 84.6 percent to 86 percent; meningococcal conjugate (MenACWY) from 74 percent to 77.8 percent; human papillomavirus (HPV) among females from 53.8 percent to 57.3 percent; and HPV among males from 20.8 percent to 34.6 percent. Coverage varied by state and local jurisdictions and by U.S. Department of Health and Human Services region. Healthy People 2020 vaccination targets for adolescents ages 13 to 15 years were reached in 42 states for Tdap, 18 for MenACWY and 11 for varicella (a catch-up vaccine).

BSTQ Staff
BioSupply Trends Quarterly [BSTQ] is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace. With timely and critical information, each themed issue covers topics ranging from product breakthroughs, industry insights and innovations, up-to-the-minute news on the latest clinical trials, accessibility, and service and safety concerns.